week 3 of tirzepatide 2 results Week 3! 2.5mg Still no side effects. Still feeling less/almost What to Expect When Starting

RCT SCALE Study - Liraglutide vs Placebo for Weight Loss in Overweight Nondiabetic Adults, NEJM (2015) [PubMed abstract] The SCALE study enrolled 3731 overweight adults who did not have diabetes Main inclusion criteria BMI 30

Bloating is a feeling of fullness or swelling in the abdominal area and can be both uncomfortable and distressing

A pharmacy may be allowed to prepare a product under limited circumstances without the product becoming an FDA-approved treatment

Current estimates suggest: Approximately 900,000 people living with dementia in the UK (Alzheimer's Society) Two-thirds of these have Alzheimer's disease (approximately 600,000 people) Projected to rise to 1.6 million by 2040 as the population ages Healthcare and social care costs exceed 26 billion annually Informal caregiving burden is enormous, affecting family members' employment and wellbeing This disease burden explains why the NHS and research community continue pursuing disease-modifying treatments, despite repeated setbacks like the LIFT-AD trial failure